Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP). (Q50940964)

From Wikidata

Jump to navigation Jump to search

scientific article published on 28 March 2015

Language	Label	Description	Also known as
English	Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP).	scientific article published on 28 March 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

1 reference

based on heuristic

inferred from title

methylprednisolone

1 reference

based on heuristic

inferred from title

2

object named as

Ettore Beghi

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

author name string

Davide Dalla Costa

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Paola Carignano

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Cristina Pagliacci

4

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Franco Faccioli

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Elisabetta Pupillo

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Paolo Messina

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Alfredo Gorio

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Tiziana Redaelli

9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

publication date

28 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Neurological Sciences

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

36

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

1567-1574

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

Repairing the injured spinal cord

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Neuropathology: the foundation for new treatments in spinal cord injury

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Reactive astrocytes protect tissue and preserve function after spinal cord injury

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury.

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice.

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

The applied neuropathology of human spinal cord injury

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Repair of spinal cord injuries: where are we, where are we going?

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Recombinant human erythropoietin in the treatment of acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Neural progenitor cells treated with EPO induce angiogenesis through the production of VEGF.

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Erythropoietin and the effect of oxygen during proliferation and differentiation of human neural progenitor cells.

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord I

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

SCIM – spinal cord independence measure: a new disability scale for patients with spinal cord lesions

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

A critical review of visual analogue scales in the measurement of clinical phenomena

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Neurologic recovery after traumatic spinal cord injury: data from the Model Spinal Cord Injury Systems

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Erythropoietin: recent developments in the treatment of spinal cord injury

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Spinal cord injury is accompanied by chronic progressive demyelination.

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Pharmacological aids to locomotor training after spinal injury in the cat

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

Assessment of impairment in patients with acute traumatic spinal cord injury: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1007/S10072-015-2182-5

21 January 2018

A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin-mediated preservation of the white matter in rat spinal cord injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological therapy of spinal cord injury during the acute phase

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological interventions for acute spinal cord injury

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythropoietin effect on sensorimotor recovery after contusive spinal cord injury: an electrophysiological study in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structural and functional regeneration in the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intrathecal baclofen for severe spinal spasticity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recovery following complete paraplegia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrater reliability of a modified Ashworth scale of muscle spasticity

1 reference

https://pubmed.ncbi.nlm.nih.gov/25820146

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10072-015-2182-5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/25820146

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50940964&oldid=2210588511"